首页> 外文期刊>Pediatric blood & cancer >Neuropsychological functioning of children treated with intensive chemotherapy followed by myeloablative consolidation chemotherapy and autologous hematopoietic cell rescue for newly diagnosed CNS tumors: an analysis of the Head Start II survivors.
【24h】

Neuropsychological functioning of children treated with intensive chemotherapy followed by myeloablative consolidation chemotherapy and autologous hematopoietic cell rescue for newly diagnosed CNS tumors: an analysis of the Head Start II survivors.

机译:强化化疗,清髓性巩固化疗和自体造血细胞抢救治疗新诊断的CNS肿瘤的儿童的神经心理功能:Head Start II幸存者的分析。

获取原文
获取原文并翻译 | 示例
       

摘要

BACKGROUND: To evaluate the neuropsychological late effects amongst survivors treated on the Head Start II protocol between 1997 and 2003. PROCEDURES: Forty-nine patients (mean age 2.9 years) diagnosed with a malignant brain tumor underwent baseline neuropsychological assessment prior to autologous hematopoietic cell transplantation (AuHCT). Twenty-six survivors were retested after 3 years of follow-up as 20 patients did not survive. Patients were evaluated for intelligence, academic achievement, receptive language, visual-motor integration (VMI), learning/memory, social-emotional and behavioral functioning based upon age at testing. RESULTS: Overall intelligence and VMI at baseline were low average while verbal and non-verbal intelligence, academic achievement, and receptive vocabulary were in average range. Parents reported social-emotional and behavioral functioning within normal limits. Serial testing revealed Full Scale (FSIQ)/Mental Development Index (MDI), Verbal (VIQ), and Performance (PIQ) Intelligence to be generally stable over 3-year follow-up. Group-average analysis at follow-up demonstrated low average intelligence, academic achievement, receptive language, and VMI. Age at diagnosis was positively correlated with internalizing symptoms and visual immediate memory, while time since diagnosis was inversely correlated with FSIQ, VIQ, PIQ, reading and delayed verbal memory. Craniospinal irradiation (CSI) was avoided in two-thirds of patients. CONCLUSION: Induction, with or without intensification using intravenous methotrexate, followed by myeloablative consolidation chemotherapy with AuHCT, may avoid or delay CSI, with possible stabilization of neuropsychological functioning, including those younger at diagnosis. Continued follow-up is necessary to determine the preservation of neuropsychological, academic, social-emotional and behavioral functioning.
机译:背景:在1997年至2003年之间,评估在接受Head Start II方案治疗的幸存者中的神经心理后期影响。程序:对49名诊断为恶性脑肿瘤的患者(平均年龄2.9岁)在进行自体造血细胞移植之前进行了基线神经心理评估。 (AuHCT)。随访3年后对26名幸存者进行了重新测试,原因是20名患者未能幸存。根据测试时的年龄对患者进行智力,学业成绩,接受语言,视觉运动整合(VMI),学习/记忆,社交情感和行为功能方面的评估。结果:基线时的总体智力和VMI平均值较低,而言语和非语言智力,学习成绩和接受词汇的平均值处于中等范围。父母报告说在正常范围内有社交情绪和行为功能。串行测试显示,在三年的随访中,全面(FSIQ)/精神发展指数(MDI),语言(VIQ)和绩效(PIQ)智力通常保持稳定。随访中的小组平均分析显示出较低的平均智力,学习成绩,接受语言和VMI。诊断时的年龄与内在症状和视觉即时记忆成正相关,而自诊断以来的时间与FSIQ,VIQ,PIQ,阅读和延迟的言语记忆成反比。三分之二的患者避免了颅骨放射线照射(CSI)。结论:在静脉内使用甲氨蝶呤进行有无强化诱导,然后用AuHCT进行清髓性强化化疗,可以避免或延迟CSI,并可能使神经心理学功能稳定,包括那些诊断较年轻的患者。持续的随访对于确定神经心理学,学术,社会情感和行为功能的保存是必要的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号